Mirae Asset Global Investments’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Mirae Asset Global Investments’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.79K	Sell	5,020 -835	-14%	-$1.7K	﹤0.01%	1572
2026 Q1	$14.4K	Sell	5,855 -1,728	-23%	-$5.78K	﹤0.01%	1466
2025 Q4	$30.2K	Buy	+7,583	New	+$33.6K	﹤0.01%	1486
2022 Q2	–	Sell	-58,466	Closed	-$949K	–	2420
2022 Q1	$949K	Sell	58,466 -2,484	-4%	-$63.7K	﹤0.01%	1338
2021 Q4	$2.89M	Buy	60,950 +26,920	+79%	+$1.62M	0.01%	1033
2021 Q3	$2.47M	Buy	34,030 +30,500	+864%	+$2.21M	0.01%	1056
2021 Q2	$297K	Buy	+3,530	New	+$233K	﹤0.01%	1583

Other funds holding NBP

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Mirae Asset Global Investments's NBP Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 14% in Q2 2026, selling an estimated $1.7K and leaving 5,020 shares worth $9.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

Mirae Asset Global Investments first reported a position in NBP in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.89M in Q4 2021. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Mirae Asset Global Investments held 5,020 shares of NovaBridge Biosciences American Depositary Shares worth $9.79K as of Q2 2026.
Mirae Asset Global Investments sold 835 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $1.7K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1572 holding.
Mirae Asset Global Investments first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 7 quarters since.
Mirae Asset Global Investments's NovaBridge Biosciences American Depositary Shares position peaked at $2.89M in Q4 2021.
6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.